Meluzio Michael Vincent (CIK 2138368) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Buy CUE (13,647 shares), Sell CUE (1,519 shares), Sell CUE (4,106 shares), Sell CUE (3 shares), Buy CUE (40,942 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Cue Biopharma, Inc. (CUE) | VP, Prin. Accounting Officer | Buy | 13,647 | $0 |
| 2026-08-17 | Cue Biopharma, Inc. (CUE) | VP, Prin. Accounting Officer | Sell | 1,519 | $44,613 |
| 2026-08-17 | Cue Biopharma, Inc. (CUE) | VP, Prin. Accounting Officer | Sell | 4,106 | $124,617 |
| 2026-08-17 | Cue Biopharma, Inc. (CUE) | VP, Prin. Accounting Officer | Sell | 3 | $93 |
| 2026-07-10 | Cue Biopharma, Inc. (CUE) | VP, Prin. Accounting Officer | Buy | 40,942 | $0 |
Source: SEC Form 4 filings · as of 2026-08-17